Smith Thornton Advisors LLC Abbott Laboratories Transaction History
Smith Thornton Advisors LLC
- $158 Billion
- Q4 2024
A detailed history of Smith Thornton Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 3,886 shares of ABT stock, worth $488,081. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,886
Previous 3,886
-0.0%
Holding current value
$488,081
Previous $443 Million
0.79%
% of portfolio
0.28%
Previous 0.29%
Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,377Shares Held
1.33BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.5 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.69 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.54 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.79 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $220B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...